ScopusElsevier Scopus
Status
Active
Coverage
2017–present
Source type
Journal
Open access
Yes
CiteScore
11.8
SJR · SCImago
3.110
Q1 SJR quartile
H-index
110
Best quartile
Q1 · 91st pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 13 / 151 | 91st | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Blood Advances
Blood Advances is Scopus-indexed (Q1, CiteScore 11.8), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by American Society of Hematology.
Checked against the index lists dated .
ISSN 2473-9529Verify ISSN ↗2473-9537Verify ISSN ↗
Publisher: American Society of Hematology
Scopus · Q1WoS · SCIEOpen AccessONOS APC
11.8
CiteScore 2025
Q1
Best quartile
3
Indexed in
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Authors affiliated with an ONOS-subscribed Indian institution can publish in this journal with the Article Processing Charge (APC) covered centrally under One Nation One Subscription — no personal APC payment.
Eligibility depends on your institution and the current ONOS list, which is subject to revision — verify before submitting.
Check the ONOS APC portal Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Quick answers
Is Blood Advances indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q1, CiteScore 11.8.
What quartile is Blood Advances in Scopus?
Blood Advances is Q1 in Hematology (rank 13 of 151), by CiteScore 2025.
What is the impact factor of Blood Advances?
Blood Advances is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 11.8, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.110, quartile Q1, with an H-index of 110.
How much does it cost to publish in Blood Advances?
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$3,800 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Blood Advances and what is its ISSN?
Blood Advances is published by American Society of Hematology. Its print ISSN is 2473-9529 and its online ISSN is 2473-9537.
Is Blood Advances covered under ONOS in India?
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Is Blood Advances in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Blood Advances open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Blood Advances? — open metrics via OpenAlex
Blood Advances has an h-index of 133 and a 2-year mean of 5.65 citations per paper (OpenAlex). Its Scopus CiteScore is 11.8, quartile Q1. On 2-year citations it ranks #10 of 148 Scopus journals in Hematology.
133
h-index
5.65
2-yr mean citations
3,589
i10-index
6,271
works indexed
162,010
total citations
Publication fee · open access list price, US$
US$3,800
2-yr mean citations, among Scopus journals in the same subject
#10 of 148 Top 7% Hematology
Blood Advances published 791 papers in 2025. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Blood Advances? — latest 97 articles, 2026
In its latest 97 research articles (2026), authors are most often from United States (49.3%), Germany (6.1%) and United Kingdom (5.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Blood Advances? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 0.3 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Hematology (United States) Scopus Q2 WoS SCIE Blood Cancer Journal Scopus Q1 WoS SCIE DOAJ Blood Cells, Molecules, and Diseases Scopus Q2 WoS SCIE Blood Coagulation and Fibrinolysis Scopus Q3 WoS SCIE Blood Neoplasia Scopus Q4 DOAJ Blood Research Scopus Q2 WoS ESCI DOAJ Blood Reviews Scopus Q1 WoS SCIE Blood Science Scopus Q2 WoS ESCI DOAJ
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.